Latest Commercialization News

Critica Limited has declared a maiden Inferred Mineral Resource Estimate for its Jupiter Project, establishing it as Australia’s largest and highest-grade clay-hosted rare earth deposit. Early metallurgical testwork shows promising beneficiation results, positioning the company as a strategic player in the rare earths sector.

Global Uranium and Enrichment Limited has significantly expanded its Pine Ridge Uranium Project landholding in Wyoming’s Powder River Basin by approximately 85%, adding 937 new claims and enhancing exploration potential in a premier U.S. uranium district.

Hiremii Limited has completed its 2024-25 AI recruitment platform roadmap nine weeks early, with its proprietary AI outperforming industry shortlisting benchmarks. Despite a slight revenue decline due to market slowdowns, the company is poised for growth through technology commercialization and strategic M&A.

Sunshine Metals has launched a targeted reverse circulation drilling program at Liontown to upgrade shallow oxide gold and silver resources and advance metallurgical studies, aiming to fast-track development amid strong gold prices.

Bubs Australia has triumphed in a long-standing legal dispute, winning $26.5 million in arbitration awards against Alpha Group subsidiaries Alice Trading and Willis Trading. The company now faces the challenge of recovering the awarded sums.

Iondrive Limited confirms strong financial metrics for its proprietary DES battery recycling technology, progressing pilot plant development and divesting exploration assets to sharpen focus on commercialisation.

Venus Metals Corporation has initiated a targeted RC drilling program at its Sandstone Bellchambers Gold Project aiming to upgrade and expand its existing gold resource. The company is also advancing mining lease applications and negotiating potential sales agreements to position the project for future development.

Simble Solutions reported a 39% rise in customer cash receipts for Q1 FY25 and strengthened its market position through strategic partnerships and renewable energy initiatives.

Medical Developments International reported a robust Q3 FY25 with $8.9 million revenue and $1.7 million operating cashflow, driven by strong Penthrox demand and pricing. New distribution agreements in France and Switzerland position the company for further European expansion.

LTR Pharma reports strong Q1 2025 progress with FDA pre-IND meeting success, scientific acclaim for SPONTAN’s rapid absorption, and strategic launch of ROXUS to fast-track US market entry.

Syrah Resources halts production at its Balama graphite mine amid ongoing protests while advancing its US-based Vidalia anode material facility, securing a significant $165 million US tax credit and forging key offtake deals.

HyTerra Limited has initiated a 12-month exploration program at its Nemaha Project in Kansas, successfully spudding the Sue Duroche 3 well and commencing seismic surveys to assess natural hydrogen potential.